🇬🇧·2d agoResearch
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy
Publisher
n
npj Precision Oncology
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: npj Precision Oncology
Scope: Research
Related coverage
More related coverage
Dana-Farber Cancer Institute·22h ago
How AML Leukemia Cells Use a “Sugar Coat” to Hide from the Immune System, CRISPR Screen Finds
Dana-Farber Cancer Institute researchers, in collaboration with the Broad Institute and Mass General...
npj Precision Oncology·1d ago
Integrative molecular analyses of lineage identity and morphology in aggressive variant prostate cancer
npj Precision Oncology·1d ago
CD18-targeted peptide-drug conjugate remodels the immunosuppressive tumor microenvironment of prostate cancer by selective depletion of M2 macrophages
The Royal Marsden NHS Foundation Trust·2d ago
Digital upgrade to histopathology service reduces wait time for cancer diagnosis
State-of-the-art scanners and advanced image management software allow for more efficient service.